[Improved clinical course of herpes zoster in immunosuppressed patients treated with fibroblast interferon].

In a randomized study with patients suffering from herpes zoster spread of eruptions was inhibited and segmental pain was reduced rapidly by continuous infusion of daily 0.5 X 10(6) IE fibroblast interferon/kg body weight for 3-5 days. Postherpetic neuralgia was observed more rarely and interferon healing of eruptions was accelerated by interferon compared to the controls.

RCT Entities:   Population Interventions Outcomes